Cours CytRx Corporation Nasdaq
Actions
US2328285091
Recherche biotechnologique et médicale
CA 2022 | - | CA 2023 | - | Capitalisation | 644 k 585 k |
---|---|---|---|---|---|
Résultat net 2022 | -4 M -3,63 M | Résultat net 2023 | - 0 | VE / CA 2022 | - |
Trésorerie nette 2022 | 1,15 M 1,04 M | Trésorerie nette 2023 | 2,04 M 1,85 M | VE / CA 2023 | - |
PER 2022 |
-1,05
x | PER 2023 |
1,91
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 99,44% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Stephen Snowdy
CEO | Chief Executive Officer | 55 | 10/01/22 |
John Caloz
DFI | Director of Finance/CFO | 72 | 01/10/07 |
Cristina Newman
SEC | Corporate Secretary | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Jennifer Simpson
CHM | Chairman | 55 | 29/07/21 |
Cary Claiborne
BRD | Director/Board Member | 64 | 27/07/22 |
Joel Caldwell
BRD | Director/Board Member | 69 | 12/07/17 |
Varia. 1 janv. | Capi. | |
---|---|---|
-0,09% | 42,12 Md | |
+49,62% | 42,05 Md | |
-4,96% | 29,18 Md | |
+11,18% | 26,02 Md | |
-21,95% | 18,9 Md | |
+8,61% | 13,21 Md | |
+24,73% | 12,17 Md | |
+28,31% | 12,16 Md | |
-6,26% | 11,42 Md |